This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

4/15/2026 6:59:06 PM | less than a minute read

FDA Announces a Single Pivotal Trial as the New Default Standard for All Drug Approvals and Unveils a Plausible Mechanism Framework for Individualized Therapies

Get in touch

Samarth Parikh

Associate

Kyle Dolinsky

Partner

Get in touch

Samarth Parikh

Associate

Kyle Dolinsky

Partner

FDA shifts to a single pivotal trial default and issues plausible mechanism guidance to speed individualized therapies for rare genetic diseases.

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration (FDA), a federal agency of the Department of Health and Human Services (HHS).

Get in touch

Samarth Parikh

Associate

Kyle Dolinsky

Partner

Get in touch

Samarth Parikh

Associate

Kyle Dolinsky

Partner

Latest Insights

AI State Regulatory Frontiers: Predictive, Generative, and Agentic Risk

4/15/2026 7:00:34 PM

AI State Regulatory Frontiers: Predictive, Generative, and Agentic Risk

By Ashley Taylor

Hot Flashes, Cold Policies: Legal and Benefit Strategies for Menopause

4/14/2026 7:23:20 PM

Hot Flashes, Cold Policies: Legal and Benefit Strategies for Menopause

By Lydia Parker Emily Schifter Tracey Diamond

StubHub to Refund $10M in 'Junk Fees' as Part of Latest FTC Settlement

4/14/2026 7:22:00 PM

StubHub to Refund $10M in 'Junk Fees' as Part of Latest FTC Settlement

By Namrata Kang Clayton Friedman

Debunking Myths Every Copyright Defendant Has Told Themselves

4/14/2026 7:20:24 PM

Debunking Myths Every Copyright Defendant Has Told Themselves

By Di'Vennci Lucas Michael Hobbs